Store
Sepsis Diagnostics Products and Market Trends
Publication Date: October 26, 2020
Tags: COVID-19, Diagnostic Instruments, Infectious Disease Testing Instruments, Mass Spectrometry, Next-Generation Sequencing (NGS), Next-Generation Sequencing (NGS) Systems, Point-of-Care (POC) Testing, Sequencing
Pages: 55
SKU: 20-046
Sepsis poses one of the greatest challenges in healthcare today, with approximately 1.7 million cases and 270,000 deaths annually in the United States alone. The condition is the most expensive to treat in US hospitals, highlighting the urgent need for effective diagnosis and treatment solutions. Kalorama Information’s report, Sepsis Diagnostics Products and Market Trends, provides an in-depth examination of the sepsis market, detailing current trends, emerging technologies, and the impact of COVID-19.
Key Features of the Report:
This comprehensive report offers valuable data and business planning resources, including:
- Sepsis Detection Practice Trends: Insights into current practices for detecting sepsis.
- Sepsis-Related Biomarkers: Analysis of biomarkers, their advantages, and disadvantages.
- Market Overview: Detailed market analysis for sepsis-related testing.
- Technological Innovations: Examination of mass spectrometry and its application in sepsis diagnosis.
- COVID-19 Impact: Special focus on the interplay between COVID-19 and sepsis.
- Sepsis Testing Products: Categorized by technology, including POC, AST, Culture/ID, NGS, Host Response, and amp-free isothermal methods, along with their approval statuses.
Market Insights:
- Complexity of Sepsis Diagnosis: Despite being the gold standard, blood culture analysis is slow and labor-intensive. The overlap of sepsis with other infectious diseases necessitates a broad range of products and technologies.
- Rapid and Multiplexed Tests: Emphasis on the importance of rapid and multiplexed tests for effective sepsis diagnosis.
- Infectious Disease Diagnostics: While the report covers systems and products for diagnosing infectious diseases, it does not provide a comprehensive breakdown of all products in this category.
- Additional Tests: Overview of other relevant tests such as blood gases, bilirubin, creatinine, and platelets, which may be conducted based on clinical needs.
Competitive Landscape:
The report profiles key players in the sepsis diagnostics and treatment market, providing insights into their products, technologies, and market strategies.
COVID-19 Impact Analysis:
A dedicated section explores the significant impact of the COVID-19 pandemic on sepsis diagnosis and treatment, discussing the challenges and new opportunities arising from the pandemic.
For further details and to purchase directly, please contact us.
Table of Contents
CHAPTER 1: EXECUTIVE SUMMARY
OVERVIEW
PROFESSIONAL GUIDELINES AND DEFINITIONS
- SIRS Criteria and Sepsis-1
- Sepsis-2
- Sepsis-3
- Sequential (Sepsis-related) Organ Failure (SOFA), qSOFA
MARKET CONSIDERATIONS
-
- Figure 1-1: Approximate Sepsis-Related Test Markets (CRP Market for All Applications, PCT Test Market for All Applications, Sepis-Purposed HAIs)
CHAPTER 2: TESTING OF HOST RESPONSE
-
- Table 2-1: Top Biomarkers Used in Sepsis
PROCALCITONIN (PCT)
- Advantages
- Disadvantages
CRP
- Advantages
- Disadvantages
LACTATE
CYTOKINES
RNA, MRNA, MICRORNA (MIRNA)
PROADRENOMEDULLIN (PROADM)
D-DIMER
MULTI-MARKER APPROACHES
CHAPTER 3: PATHOGEN DETECTION/ IDENTIFICATION AND ANTIMICROBIAL SUSCEPTIBILITY TESTING
MULTIPLEX MOLECULAR ASSAYS
Multiplex Molecular Assays Used for Sepsis
-
- Table 3-1: Multiplex Molecular Assays Used for Sepsis
MASS SPECTROMETRY ACHIEVING POPULARITY
- Wide Selection of Products for Microbe ID, AST
- Table 3-2: Selected Mass Spectrometry Products Used for Microbial ID and AST
- Table 3-3: Systems and Products for Bacterial Culture, Staining, Incubation
CHAPTER 4: COVID-19 AND SEPSIS
COVID-19 AND OVERLAP WITH SEPSIS
CHAPTER 5: MAJOR SEPSIS-RELATED PRODUCTS ON THE MARKET
-
- Table 5-1: Sepsis Products on the Market
Related products
Molecular Diagnostics in Oncology, Genetic/Inherited Diseases, and NIPT, 2023-2028
November 29, 2023
In recent decades, genetic technologies for research and diagnostics have transformed healthcare, offering new possibilities in precision medicine and disease management. Next-generation sequencing (NGS) has revolutionized genetic disease diagnostics and oncology, providing comprehensive insights at a relatively low cost. PCR continues to evolve, remaining a central tool in molecular diagnostics. In situ hybridization techniques (ISH)…
Price range: $5,000.00 through $7,500.00
The Worldwide Market for Clinical Laboratory Services, 9th Edition
June 25, 2024
Understanding the clinical laboratory market is crucial for effective business planning. The Worldwide Market for Clinical Laboratory Services, 9th Edition answers essential questions such as the size of the service market for clinical testing, the types of tests that are in demand, and the future trajectory of this market 2023-2028. It also identifies the companies…
Price range: $5,000.00 through $7,500.00
Clinical Laboratory Services Market, 8th Edition
May 18, 2023
Laboratories are the workhorse of diagnostic services for the IVD market. These laboratories play a vital role in providing analysis of a wide range of disorders and diseases including pathology, immunology, cholesterol testing, allergy testing, urinalysis, genetic testing and many more. Kalorama Information’s Clinical Laboratory Services Market, 8th Edition is your comprehensive resource for insights…
Price range: $4,000.00 through $6,000.00
